DAX ®13.172,30+0,26%TecDAX ®3.009,91+0,52%S&P FUTURE3.114,00+0,33%Nasdaq 100 Future8.260,75-0,37%
finanztreff.de

DGAP-CMS: Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

| Quelle: Dow Jones Newsw... | Lesedauer etwa 2 min. | Text vorlesen Stop Pause Fortsetzen


DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co.
KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of
Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU)
2016/1052
Fresenius Medical Care AG & Co. KGaA: Release of a capital market
information

2019-10-21 / 13:02
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

- Share buy-back - 18th Interim Report

In the period from October 14, 2019 until and including October 18, 2019, a
total of 205,025 shares were repurchased within the framework of the share
buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius
Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a)
of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation
(EU) 2016/1052.

The purchase was carried out exclusively by a credit institution
commissioned by Fresenius Medical Care via the XETRA trading platform on the
Frankfurt Stock Exchange:

*Day of repurchase * *Aggregated volume in *Weighted average
number of shares * share price*
*in EUR *
14.10.2019 26,025 EUR 59.0577
15.10.2019 30,000 EUR 60.7184
16.10.2019 35,000 EUR 61.5797
17.10.2019 75,000 EUR 61.9820
18.10.2019 39,000 EUR 61.2061

The total volume of shares repurchased within the framework of this share
buy-back in the period from June 17, 2019 until and including October 18,
2019 therefore amounts to 3,315,524 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of
Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's
website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., October 21, 2019

2019-10-21 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

End of News DGAP News Service

893365 2019-10-21



(END) Dow Jones Newswires

October 21, 2019 07:02 ET ( 11:02 GMT)
Werbung

Passende Hebelprodukte von

WKN Bezeichnung Hebel
Long  DC4LQ3 FMC WaveUnlimited L 56.9281 (DBK) 6,952
Short  DC54H9 FMC WaveXXL S 71.35 (DBK) 7,026
Werbung

Das könnte Sie auch interessieren

Im Artikel erwähnt...

FMC
FMC - Performance (3 Monate) 66,68 +0,97%
EUR +0,64
Porträt - Chart - Kennzahlen - Firmenprofil
Fundamentale Analysen Urteil
18.11. HSBC Positiv
12.11. BERNSTEIN RESEARCH Neutral
05.11. JPMORGAN Positiv
Nachrichten

09:01
Deutsche Bank X-markets
Fresenius Medical Care AG : Kreuzen des GD 200 nach oben (66.58 Euro, Long) FMC 66,68 +0,97%
20.11. Fresenius Medical Care platziert Anleihen über 1,75 Mrd Euro FMC 66,68 +0,97%

20.11.
Morgan Stanley
Aktie im Fokus - Fresenius Medical Care FMC 66,68 +0,97%
Weitere Wertpapiere...
FRESENIUS MD.CARE ADR 1/2 33,20 +1,22%
EUR +0,40

News-Suche

Suchbegriff:
Werbung

Werbung
Diese Seite empfehlenschliessen
Interessant, oder?
Teilen Sie diese Seite auf Facebook oder Twitter
Wenn Sie auf die Teilen-Buttons klicken und sich bei den Betreibern einloggen, werden Daten an den jeweiligen Betreiber übermittelt. Bitte beachten Sie die Datenschutzerklärung.
Aktuelle Umfrageschliessen
Elon Musk hat vor in der Nähe von Berlin eine Gigafabrik zu bauen. Ist das eher ein Segen für die Region und Deutschland oder eher eine Kampfansage an die deutschen Autobauer?
Jetzt abstimmen!
Alle Umfragen ansehen